Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT01632241 · COMPLETED
Trial details
- NCT number
- NCT01632241
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-19
- Primary completion
- 2018-06-18
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.